Anti‐Programmed death‐1 therapy in advanced hepatocellular carcinoma: A real‐world experience

Anti‐Programmed death‐1 therapy in advanced hepatocellular carcinoma: A real‐world experience

Abstract Nivolumab is an effective and safe treatment in HCC.

Bibliographic Details
Main Authors: Ouissam Al jarroudi, Hamed Chaabouni, Ayhan Ulusakarya, Wathek Almohamad, Yusuf Gumus, Emma Goldschmidt, Said Afqir, Jean‐francois Morère
Format: Article
Language:English
Published: Wiley 2021-04-01
Series:Clinical Case Reports
Subjects:
clinical outcomes
hepatocellular carcinoma
nivolumab
survival
Online Access:https://doi.org/10.1002/ccr3.3970
id doaj-e758a507356a45148acf63bdc32d8cbc
record_format Article
spelling doaj-e758a507356a45148acf63bdc32d8cbc2021-05-15T18:35:45ZengWileyClinical Case Reports2050-09042021-04-01942162216710.1002/ccr3.3970Anti‐Programmed death‐1 therapy in advanced hepatocellular carcinoma: A real‐world experienceOuissam Al jarroudi0Hamed Chaabouni1Ayhan Ulusakarya2Wathek Almohamad3Yusuf Gumus4Emma Goldschmidt5Said Afqir6Jean‐francois Morère7Medical Oncology Department AP‐HPPaul Brousse Hospital Villejuif FranceMedical Oncology Department AP‐HPPaul Brousse Hospital Villejuif FranceMedical Oncology Department AP‐HPPaul Brousse Hospital Villejuif FranceMedical Oncology Department AP‐HPPaul Brousse Hospital Villejuif FranceMedical Oncology Department AP‐HPPaul Brousse Hospital Villejuif FranceMedical Oncology Department AP‐HPPaul Brousse Hospital Villejuif FranceMedical Oncology Department University Hospital Mohammed VI‐Oujda Oujda MoroccoMedical Oncology Department AP‐HPPaul Brousse Hospital Villejuif FranceAbstract Nivolumab is an effective and safe treatment in HCC.https://doi.org/10.1002/ccr3.3970clinical outcomeshepatocellular carcinomanivolumabsurvival
collection DOAJ
language English
format Article
sources DOAJ
author Ouissam Al jarroudi
Hamed Chaabouni
Ayhan Ulusakarya
Wathek Almohamad
Yusuf Gumus
Emma Goldschmidt
Said Afqir
Jean‐francois Morère
spellingShingle Ouissam Al jarroudi
Hamed Chaabouni
Ayhan Ulusakarya
Wathek Almohamad
Yusuf Gumus
Emma Goldschmidt
Said Afqir
Jean‐francois Morère
Anti‐Programmed death‐1 therapy in advanced hepatocellular carcinoma: A real‐world experience
Clinical Case Reports
clinical outcomes
hepatocellular carcinoma
nivolumab
survival
author_facet Ouissam Al jarroudi
Hamed Chaabouni
Ayhan Ulusakarya
Wathek Almohamad
Yusuf Gumus
Emma Goldschmidt
Said Afqir
Jean‐francois Morère
author_sort Ouissam Al jarroudi
title Anti‐Programmed death‐1 therapy in advanced hepatocellular carcinoma: A real‐world experience
title_short Anti‐Programmed death‐1 therapy in advanced hepatocellular carcinoma: A real‐world experience
title_full Anti‐Programmed death‐1 therapy in advanced hepatocellular carcinoma: A real‐world experience
title_fullStr Anti‐Programmed death‐1 therapy in advanced hepatocellular carcinoma: A real‐world experience
title_full_unstemmed Anti‐Programmed death‐1 therapy in advanced hepatocellular carcinoma: A real‐world experience
title_sort anti‐programmed death‐1 therapy in advanced hepatocellular carcinoma: a real‐world experience
publisher Wiley
series Clinical Case Reports
issn 2050-0904
publishDate 2021-04-01
description Abstract Nivolumab is an effective and safe treatment in HCC.
topic clinical outcomes
hepatocellular carcinoma
nivolumab
survival
url https://doi.org/10.1002/ccr3.3970
work_keys_str_mv AT ouissamaljarroudi antiprogrammeddeath1therapyinadvancedhepatocellularcarcinomaarealworldexperience
AT hamedchaabouni antiprogrammeddeath1therapyinadvancedhepatocellularcarcinomaarealworldexperience
AT ayhanulusakarya antiprogrammeddeath1therapyinadvancedhepatocellularcarcinomaarealworldexperience
AT wathekalmohamad antiprogrammeddeath1therapyinadvancedhepatocellularcarcinomaarealworldexperience
AT yusufgumus antiprogrammeddeath1therapyinadvancedhepatocellularcarcinomaarealworldexperience
AT emmagoldschmidt antiprogrammeddeath1therapyinadvancedhepatocellularcarcinomaarealworldexperience
AT saidafqir antiprogrammeddeath1therapyinadvancedhepatocellularcarcinomaarealworldexperience
AT jeanfrancoismorere antiprogrammeddeath1therapyinadvancedhepatocellularcarcinomaarealworldexperience
_version_ 1721440527655632896

Similar Items